SCHEMBL7560223

SCHEMBL7560223

[c]1cccc2c1NC=CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565754 0.68
SCHEMBL170456 0.66 PLAU (0.43)
SCHEMBL29504825 0.66 PLAU (0.43)
SCHEMBL4513586 0.66 TSHR (0.31)
SCHEMBL4848367 0.66
SCHEMBL31312839 0.64 PLAU (0.42)
SCHEMBL8827973 0.64 PLAU (0.42)
Hydrochloric Acid SCHEMBL10824104 0.64 PLAU (0.42)
SCHEMBL277639 0.64
SCHEMBL107331 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002069972-A2 TRIAZOLE COMPOUNDS AND THE USE THEREOF IN THE PROPHYLAXIS AND THERAPY OF NEURODEGENERATIVE DISEASES, CEREBRAL TRAUMA AND CEREBRAL ISCHEMIA ABBOTT GMBH & CO. KG (DE) 2002-09-12 WO claimed
WO-2002069972-A2 TRIAZOLE COMPOUNDS AND THE USE THEREOF IN THE PROPHYLAXIS AND THERAPY OF NEURODEGENERATIVE DISEASES, CEREBRAL TRAUMA AND CEREBRAL ISCHEMIA ABBOTT GMBH & CO. KG (DE) 2002-09-12 WO disclosed
US-5049560-A Anticoagulants, platelet activating factor SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 1991-09-17 US disclosed